Workflow
东瑞制药(02348) - 致登记股东之通知信函及回条 - 2025中期报告之刊发通知
东瑞制药东瑞制药(HK:02348)2025-09-11 11:07

Dawnrays Pharmaceutical (Holdings) Limited 東瑞製葯(控股)有限公司 (Incorporated in the Cayman Islands with limited liability) (於開曼群島註册成立之有限公司) (Stock Code 股份代號:2348) NOTIFICATION LETTER 通知信函 Dear Registered Shareholders, Dawnrays Pharmaceutical (Holdings) Limited (the "Company") – Notice of publication of 2025 Interim Report (the "Current Corporate Communication") Yours faithfully, Dawnrays Pharmaceutical (Holdings) Limited Li Kei Ling Chairman Note: Corporate Communications include any document(s) issued or to be is ...